BibTex RIS Kaynak Göster

Il-1 family and its related diseases

Yıl 2019, Cilt: 8 Sayı: 1, 37 - 45, 01.01.2019

Özgür Mehmet Yiş Güler Buğdaycı

https://doi.org/10.5505/abantmedj.2019.68094

Öz

The interleukin-1 IL-1 family of members is associated with acute and chronic inflammation, and plays an essential role in the immune response. The biological properties of IL1family members are typically pro-inflammatory.The IL1 family has 11family members and can be categorized into subfamilies according to the length of their precursor. This review introduces the IL-1 family members and examines functional roles of the IL-1 family cytokines in a variety of diseases.

Anahtar Kelimeler

Interleukins cytokines disease autoimmunity inflammation

Kaynakça

  • Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. European Journal of Immunology 2011; 41(5): 1203-1217.
  • Meyer U. Anti-inflammatory signaling in schizophrenia. Brain, Behavior, and Immunity 2011; 25(8): 1507-1518.
  • Goshen I and Yirmiya R. Interleukin-1 (IL-1): A central regulator Neuroendocrinology 2009; 30(1): 30-45. Frontiers in
  • Ding C, Zhao L, Sun Y, Li L, and Xu Y. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: A meta-analysis. Archives of Oral Biology 2012; 57(6): 585-593.
  • Fichorova RN, Lai J-J, Schwartz JL, Weiner DH, Mauck CK, and Callahan MM. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non- pregnant women in microbicide trials. Cytokine 2011; 55(1): 134-140.
  • Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, and Armstrong B. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. British Journal of Haematology 2011; 152(6): 721-726.
  • Persson C, Canedo P, Machado JC, El-Omar EM, and Forman D. Polymorphisms in Inflammatory Response Genes and Their Association With Gastric Cancer: A HuGE Systematic Review and Meta-Analyses. Am. J. Epidemiol. 2011; 173(3): 259-270.
  • Peleteiro B, Lunet N, Carrilho C, Durães C, Machado JC, La Vecchia C, and Barros H. Association Between Cytokine Gene Polymorphisms and Gastric Precancerous Lesions: Systematic Review and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention 2010; 19(3): 762-776.
  • Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, Latiano A, Annese V, Caprilli R, and Delle Fave G. IL-1β-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Digestive and Liver Disease 2010; 42(3): 179-184.
  • Dinarello CA, Novick D, Kim S, and Kaplanski G. Interleukin-18 and IL-18 Binding Protein. Frontiers in Immunology 2013; 4: 289.
  • Dunn EF, Gay NJ, Bristow AF, Gearing DP, O'Neill LAJ, and Pei XY. High-Resolution Structure of Murine Interleukin 1 Homologue IL-1F5 Reveals Unique Loop Conformations for Receptor Binding Specificity. Biochemistry 2003; 42(37): 10938-10944.
  • Costelloe C, Watson M, Murphy A, McQuillan K, Loscher C, Armstrong ME, Garlanda C, Mantovani A, O’Neill LAJ, Mills KHG, and Lynch MA. IL-1F5 mediates anti- inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. Journal of Neurochemistry 2008; 105(5): 1960-1969.
  • Ramadas RA, Ewart SL, Iwakura Y, Medoff BD, and LeVine AM. IL-36α Exerts Pro-Inflammatory Effects in the Lungs of Mice. PLOS ONE 2012; 7(9): e45784.
  • Asseldonk EJP, Stienstra R, Koenen TB, Tits LJH, Joosten LAB, Tack CJ, and Netea MG. The Effect of the Interleukin-1 Cytokine Family Members IL-1F6 and IL- 1F8 on Adipocyte Differentiation. Obesity 2010; 18(11): 2234-2236.
  • Leonhardt J, Stanulla M, von Wasielewski R, Skokowa J, Kübler J, Ure BM, and Petersen C. Gene expression profile of the infective murine model for biliary atresia. Pediatric Surgery International 2006; 22(1): 84-89.
  • Gresnigt MS and van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Semin Immunol 2013; 25(6): 458-65.
  • Carrier Y, Ma H-L, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, and Medley QG. Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis. Journal of Investigative Dermatology; 131(12): 2428-2437.
  • Franzke C-W, Cobzaru C, Triantafyllopoulou A, Löffek S, Horiuchi K, Threadgill DW, Kurz T, van Rooijen N, Bruckner-Tuderman L, and Blobel CP. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation. The Journal of Experimental Medicine 2012; 209(6): 1105-1119.
  • Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, and Peschon JJ. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. The Journal of Experimental Medicine 2007; 204(11): 2603-2614.
  • Chustz RT, Nagarkar DR, Poposki JA, Favoreto S, Avila PC, Schleimer RP, and Kato A. Regulation and Function of the IL-1 Family Cytokine IL-1F9 in Human Bronchial Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2011; 45(1): 145-153.
  • Gresnigt MS and van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Seminars in Immunology 2013; 25(6): 458-465.
  • Sharma S, Kulk N, Nold MF, Gräf R, Kim S-H, Reinhardt D, Dinarello CA, and Bufler P. The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines. The Journal of Immunology 2008; 180(8): 5477-5482.
  • Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, and Dinarello CA. Interleukin 37 is a fundamental inhibitor of innate immunity. Nature immunology 2010; 11(11): 1014-1022.
  • Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, and Gabel C. IL-1 family nomenclature. Nature immunology 2010; 11(11): 973-973.
  • Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel P-Y, Siegmund K, Meyer N, Akdis CA, and Schmidt-Weber CB. Differentiation and functional analysis of human TH17 cells. Journal of Allergy and Clinical Immunology 2009; 123(3): 588-595.e7.
  • Sims JE and Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10(2): 89-102.
  • Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, and Gladman D. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis and Rheumatism 2006; 54(7): 2321-2325.
  • Guo ZS, Li C, Lin ZM, Huang JX, Wei QJ, Wang XW, Xie YY, Liao ZT, Chao SY, and Gu JR. Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han Immunogenetics 2010; 37(1): 33-37. Journal of
  • Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, and Kastelein RA. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity; 23(5): 479-490.
  • Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA, Wiesmann C, Bazan JF, and Fairbrother WJ. Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes. Structure; 17(10): 1398-1410.
  • Hardman C and Ogg G. Interleukin-33, friend and foe in type-2 immune responses. Curr Opin Immunol 2016; 42: 16-24.
  • Carriere V, Roussel L, Ortega N, Lacorre D-A, Americh L, Aguilar L, Bouche G, and Girard J-P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin- associated nuclear factor in vivo. Proceedings of the National Academy of Sciences 2007; 104(1): 282-287.
  • Roussel L, Erard M, Cayrol C, and Girard JP. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket. EMBO reports 2008; 9(10): 1006-1012.
  • Shao D, Perros F, Caramori G, Meng C, Dormuller P, Chou P-C, Church C, Papi A, Casolari P, Welsh D, Peacock A, Humbert M, Adcock IM, and Wort SJ. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased hypertension. Biochemical and Biophysical Research Communications 2014; 451(1): 8-14. arterial
  • Ni Y, Tao L, Chen C, Song H, Li Z, Gao Y, Nie J, Piccioni M, Shi G, and Li B. The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. International Journal of Molecular Sciences 2015; 16(11): 26063.
  • Moussion C, Ortega N, and Girard J-P. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? PLOS ONE 2008; 3(10): e3331.
  • Cohen ES, Scott IC, Majithiya JB, Rapley L, Kemp BP, England E, Rees DG, Overed-Sayer CL, Woods J, Bond NJ, Veyssier CS, Embrey KJ, Sims DA, Snaith MR, Vousden KA, Strain MD, Chan DT, Carmen S, Huntington CE, Flavell L, Xu J, Popovic B, Brightling CE, Vaughan TJ, Butler R, Lowe DC, Higazi DR, Corkill DJ, May RD, Sleeman MA, and Mustelin T. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun 2015; 6: 8327.
  • Goffic RL, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, and Samson M. Infection with Influenza Virus Induces IL-33 in Murine Lungs. 2011; 45(6): 1125-1132.
  • Hardman CS, Panova V, and McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013; 43(2): 488-98.
  • Hsu C-L and Bryce PJ. Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway. The Journal of Immunology 2012; 189(7): 3421-3429.
  • Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL, Decker DC, Blaine KM, Fixsen BR, Singh H, Sciammas R, and Sperling AI. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun 2013; 4: 2990.
  • Nile CJ, Barksby E, Jitprasertwong P, Preshaw PM, and Taylor JJ. Expression and regulation of interleukin-33 in human monocytes. Immunology 2010; 130(2): 172-180.
  • Polumuri SK, Jayakar GG, Shirey KA, Roberts ZJ, Perkins DJ, Pitha PM, and Vogel SN. Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists. The Journal of Immunology 2012; 189(1): 50-60.
  • Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, and McKenzie ANJ. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464(7293): 1367-1370.
  • Cayrol C and Girard J-P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences 2009; 106(22): 9021-9026.
  • Snelgrove RJ, Gregory LG, Peiró T, Akthar S, Campbell GA, Walker SA, and Lloyd CM. Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations. Journal of Allergy and Clinical Immunology 2014; 134(3): 583-592.e6.
  • Lefrançais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard J-P, and Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences 2012; 109(5): 1673-1678.
  • Lefrançais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, and Girard J-P. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proceedings of the National Academy of Sciences 2014; 111(43): 15502-15507.
  • Waern I, Lundequist A, Pejler G, and Wernersson S. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol 2013; 6(5): 911-920.
  • Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, McKenzie ANJ, Teixeira MM, Liew FY, and Xu D. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4. The Journal of Immunology 2008; 181(7): 4780-4790.
  • Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, Scarpa M, Fiocchi C, Vecchi M, and Pizarro TT. Epithelial- derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences 2010; 107(17): 8017-8022.
  • Xu D, Jiang H-R, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie ANJ, McInnes IB, and Liew FY. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences 2008; 105(31): 10913-10918.
  • Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S-i, Solomon SD, Rouleau J-L, and Lee RT. Expression and Regulation of ST2, an Interleukin-1 Cardiomyocytes and Myocardial Infarction. Circulation 2002; 106(23): 2961-2966. Family Member, in
  • Yin H, Li X, Hu S, Liu T, Yuan B, Ni Q, Lan F, Luo X, Gu H, and Zheng F. IL-33 promotes Staphylococcus aureus- infected wound healing in mice. International Immunopharmacology 2013; 17(2): 432-438.
  • Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, and Artis D. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12(11): 1045-1054.
  • Bonilla WV, Fröhlich A, Senn K, Kallert S, Fernandez M, Johnson S, Kreutzfeldt M, Hegazy AN, Schrick C, Fallon PG, Klemenz R, Nakae S, Adler H, Merkler D, Löhning M, and Pinschewer DD. The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses. Science 2012; 335(6071): 984-989.
  • Jackson DJ, Makrinioti H, Rana BMJ, Shamji BWH, Trujillo-Torralbo M-B, Footitt J, Jerico d-R, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, and Johnston SL. IL- 33–Dependent Type 2 Inflammation during Rhinovirus- induced Asthma Exacerbations In Vivo. Am. J. Respir. Crit. Care Med. 2014; 190(12): 1373-1382.
  • Oh JE, Kim B-C, Chang D-H, Kwon M, Lee SY, Kang D, Kim JY, Hwang I, Yu J-W, Nakae S, and Lee HK. Dysbiosis- induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proceedings of the National Academy of Sciences 2016; 113(6): E762-E771.
  • Sattler S, Ling G-S, Xu D, Hussaarts L, Romaine A, Zhao H, Fossati-Jimack L, Malik T, Cook HT, Botto M, Lau Y-L, Smits HH, Liew FY, and Huang F-P. IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. Journal of Autoimmunity 2014; 50: 107-122.
  • Mizutani N, Nabe T, and Yoshino S. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology 2013; 139(2): 205-18.

Il-1 ailesi ve ilişkili hastalıklar

Yıl 2019, Cilt: 8 Sayı: 1, 37 - 45, 01.01.2019

Özgür Mehmet Yiş Güler Buğdaycı

https://doi.org/10.5505/abantmedj.2019.68094

Öz

İnterlökin-1 aile IL-1F üyeleri akut ve kronik inflamasyon ile ilişkilidir ve immün cevapta esaslı bir rol oynar. IL-1 aile üyelerinin biyolojik özellikleri tipik olarak pro-inflamatuardır. IL-1 ailesi 11 üyeye sahiptir ve onların prekürsörlerinin uzunluğuna göre alt ailelere sınıflandırılabilinir. Bu çalışma IL-1 aile üyelerini tanıtır ve çeşitli hastalıklarda IL-1 ailesi sitokinlerinin işlevlerinin incelemesi amaçlanmıştır.

Anahtar Kelimeler

İnterlökinler sitokinler hastalık otoimmünite inflamasyon

Kaynakça

  • Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. European Journal of Immunology 2011; 41(5): 1203-1217.
  • Meyer U. Anti-inflammatory signaling in schizophrenia. Brain, Behavior, and Immunity 2011; 25(8): 1507-1518.
  • Goshen I and Yirmiya R. Interleukin-1 (IL-1): A central regulator Neuroendocrinology 2009; 30(1): 30-45. Frontiers in
  • Ding C, Zhao L, Sun Y, Li L, and Xu Y. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: A meta-analysis. Archives of Oral Biology 2012; 57(6): 585-593.
  • Fichorova RN, Lai J-J, Schwartz JL, Weiner DH, Mauck CK, and Callahan MM. Baseline variation and associations between subject characteristics and five cytokine biomarkers of vaginal safety among healthy non- pregnant women in microbicide trials. Cytokine 2011; 55(1): 134-140.
  • Hosgood HD, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, and Armstrong B. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk. British Journal of Haematology 2011; 152(6): 721-726.
  • Persson C, Canedo P, Machado JC, El-Omar EM, and Forman D. Polymorphisms in Inflammatory Response Genes and Their Association With Gastric Cancer: A HuGE Systematic Review and Meta-Analyses. Am. J. Epidemiol. 2011; 173(3): 259-270.
  • Peleteiro B, Lunet N, Carrilho C, Durães C, Machado JC, La Vecchia C, and Barros H. Association Between Cytokine Gene Polymorphisms and Gastric Precancerous Lesions: Systematic Review and Meta-analysis. Cancer Epidemiology Biomarkers & Prevention 2010; 19(3): 762-776.
  • Corleto VD, Pagnini C, Margagnoni G, Guagnozzi D, Torre MS, Martorelli M, Latiano A, Annese V, Caprilli R, and Delle Fave G. IL-1β-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies. Digestive and Liver Disease 2010; 42(3): 179-184.
  • Dinarello CA, Novick D, Kim S, and Kaplanski G. Interleukin-18 and IL-18 Binding Protein. Frontiers in Immunology 2013; 4: 289.
  • Dunn EF, Gay NJ, Bristow AF, Gearing DP, O'Neill LAJ, and Pei XY. High-Resolution Structure of Murine Interleukin 1 Homologue IL-1F5 Reveals Unique Loop Conformations for Receptor Binding Specificity. Biochemistry 2003; 42(37): 10938-10944.
  • Costelloe C, Watson M, Murphy A, McQuillan K, Loscher C, Armstrong ME, Garlanda C, Mantovani A, O’Neill LAJ, Mills KHG, and Lynch MA. IL-1F5 mediates anti- inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8. Journal of Neurochemistry 2008; 105(5): 1960-1969.
  • Ramadas RA, Ewart SL, Iwakura Y, Medoff BD, and LeVine AM. IL-36α Exerts Pro-Inflammatory Effects in the Lungs of Mice. PLOS ONE 2012; 7(9): e45784.
  • Asseldonk EJP, Stienstra R, Koenen TB, Tits LJH, Joosten LAB, Tack CJ, and Netea MG. The Effect of the Interleukin-1 Cytokine Family Members IL-1F6 and IL- 1F8 on Adipocyte Differentiation. Obesity 2010; 18(11): 2234-2236.
  • Leonhardt J, Stanulla M, von Wasielewski R, Skokowa J, Kübler J, Ure BM, and Petersen C. Gene expression profile of the infective murine model for biliary atresia. Pediatric Surgery International 2006; 22(1): 84-89.
  • Gresnigt MS and van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Semin Immunol 2013; 25(6): 458-65.
  • Carrier Y, Ma H-L, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, and Medley QG. Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis. Journal of Investigative Dermatology; 131(12): 2428-2437.
  • Franzke C-W, Cobzaru C, Triantafyllopoulou A, Löffek S, Horiuchi K, Threadgill DW, Kurz T, van Rooijen N, Bruckner-Tuderman L, and Blobel CP. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation. The Journal of Experimental Medicine 2012; 209(6): 1105-1119.
  • Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, Weng N, Kanaly ST, Towne JE, Willis CR, Kuechle MK, Sims JE, and Peschon JJ. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. The Journal of Experimental Medicine 2007; 204(11): 2603-2614.
  • Chustz RT, Nagarkar DR, Poposki JA, Favoreto S, Avila PC, Schleimer RP, and Kato A. Regulation and Function of the IL-1 Family Cytokine IL-1F9 in Human Bronchial Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2011; 45(1): 145-153.
  • Gresnigt MS and van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Seminars in Immunology 2013; 25(6): 458-465.
  • Sharma S, Kulk N, Nold MF, Gräf R, Kim S-H, Reinhardt D, Dinarello CA, and Bufler P. The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines. The Journal of Immunology 2008; 180(8): 5477-5482.
  • Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, and Dinarello CA. Interleukin 37 is a fundamental inhibitor of innate immunity. Nature immunology 2010; 11(11): 1014-1022.
  • Dinarello C, Arend W, Sims J, Smith D, Blumberg H, O'Neill L, Goldbach-Mansky R, Pizarro T, Hoffman H, Bufler P, Nold M, Ghezzi P, Mantovani A, Garlanda C, Boraschi D, Rubartelli A, Netea M, van der Meer J, Joosten L, Mandrup-Poulsen T, Donath M, Lewis E, Pfeilschifter J, Martin M, Kracht M, Muehl H, Novick D, Lukic M, Conti B, Solinger A, Kelk P, van de Veerdonk F, and Gabel C. IL-1 family nomenclature. Nature immunology 2010; 11(11): 973-973.
  • Burgler S, Ouaked N, Bassin C, Basinski TM, Mantel P-Y, Siegmund K, Meyer N, Akdis CA, and Schmidt-Weber CB. Differentiation and functional analysis of human TH17 cells. Journal of Allergy and Clinical Immunology 2009; 123(3): 588-595.e7.
  • Sims JE and Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10(2): 89-102.
  • Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, Greenwood C, and Gladman D. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis and Rheumatism 2006; 54(7): 2321-2325.
  • Guo ZS, Li C, Lin ZM, Huang JX, Wei QJ, Wang XW, Xie YY, Liao ZT, Chao SY, and Gu JR. Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han Immunogenetics 2010; 37(1): 33-37. Journal of
  • Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, and Kastelein RA. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines. Immunity; 23(5): 479-490.
  • Lingel A, Weiss TM, Niebuhr M, Pan B, Appleton BA, Wiesmann C, Bazan JF, and Fairbrother WJ. Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes. Structure; 17(10): 1398-1410.
  • Hardman C and Ogg G. Interleukin-33, friend and foe in type-2 immune responses. Curr Opin Immunol 2016; 42: 16-24.
  • Carriere V, Roussel L, Ortega N, Lacorre D-A, Americh L, Aguilar L, Bouche G, and Girard J-P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin- associated nuclear factor in vivo. Proceedings of the National Academy of Sciences 2007; 104(1): 282-287.
  • Roussel L, Erard M, Cayrol C, and Girard JP. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket. EMBO reports 2008; 9(10): 1006-1012.
  • Shao D, Perros F, Caramori G, Meng C, Dormuller P, Chou P-C, Church C, Papi A, Casolari P, Welsh D, Peacock A, Humbert M, Adcock IM, and Wort SJ. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased hypertension. Biochemical and Biophysical Research Communications 2014; 451(1): 8-14. arterial
  • Ni Y, Tao L, Chen C, Song H, Li Z, Gao Y, Nie J, Piccioni M, Shi G, and Li B. The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33. International Journal of Molecular Sciences 2015; 16(11): 26063.
  • Moussion C, Ortega N, and Girard J-P. The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? PLOS ONE 2008; 3(10): e3331.
  • Cohen ES, Scott IC, Majithiya JB, Rapley L, Kemp BP, England E, Rees DG, Overed-Sayer CL, Woods J, Bond NJ, Veyssier CS, Embrey KJ, Sims DA, Snaith MR, Vousden KA, Strain MD, Chan DT, Carmen S, Huntington CE, Flavell L, Xu J, Popovic B, Brightling CE, Vaughan TJ, Butler R, Lowe DC, Higazi DR, Corkill DJ, May RD, Sleeman MA, and Mustelin T. Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun 2015; 6: 8327.
  • Goffic RL, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, and Samson M. Infection with Influenza Virus Induces IL-33 in Murine Lungs. 2011; 45(6): 1125-1132.
  • Hardman CS, Panova V, and McKenzie AN. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013; 43(2): 488-98.
  • Hsu C-L and Bryce PJ. Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway. The Journal of Immunology 2012; 189(7): 3421-3429.
  • Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL, Decker DC, Blaine KM, Fixsen BR, Singh H, Sciammas R, and Sperling AI. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun 2013; 4: 2990.
  • Nile CJ, Barksby E, Jitprasertwong P, Preshaw PM, and Taylor JJ. Expression and regulation of interleukin-33 in human monocytes. Immunology 2010; 130(2): 172-180.
  • Polumuri SK, Jayakar GG, Shirey KA, Roberts ZJ, Perkins DJ, Pitha PM, and Vogel SN. Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists. The Journal of Immunology 2012; 189(1): 50-60.
  • Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, and McKenzie ANJ. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464(7293): 1367-1370.
  • Cayrol C and Girard J-P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences 2009; 106(22): 9021-9026.
  • Snelgrove RJ, Gregory LG, Peiró T, Akthar S, Campbell GA, Walker SA, and Lloyd CM. Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations. Journal of Allergy and Clinical Immunology 2014; 134(3): 583-592.e6.
  • Lefrançais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard J-P, and Cayrol C. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proceedings of the National Academy of Sciences 2012; 109(5): 1673-1678.
  • Lefrançais E, Duval A, Mirey E, Roga S, Espinosa E, Cayrol C, and Girard J-P. Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. Proceedings of the National Academy of Sciences 2014; 111(43): 15502-15507.
  • Waern I, Lundequist A, Pejler G, and Wernersson S. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation. Mucosal Immunol 2013; 6(5): 911-920.
  • Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, McKenzie ANJ, Teixeira MM, Liew FY, and Xu D. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4. The Journal of Immunology 2008; 181(7): 4780-4790.
  • Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, Scarpa M, Fiocchi C, Vecchi M, and Pizarro TT. Epithelial- derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences 2010; 107(17): 8017-8022.
  • Xu D, Jiang H-R, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie ANJ, McInnes IB, and Liew FY. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences 2008; 105(31): 10913-10918.
  • Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S-i, Solomon SD, Rouleau J-L, and Lee RT. Expression and Regulation of ST2, an Interleukin-1 Cardiomyocytes and Myocardial Infarction. Circulation 2002; 106(23): 2961-2966. Family Member, in
  • Yin H, Li X, Hu S, Liu T, Yuan B, Ni Q, Lan F, Luo X, Gu H, and Zheng F. IL-33 promotes Staphylococcus aureus- infected wound healing in mice. International Immunopharmacology 2013; 17(2): 432-438.
  • Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, and Artis D. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12(11): 1045-1054.
  • Bonilla WV, Fröhlich A, Senn K, Kallert S, Fernandez M, Johnson S, Kreutzfeldt M, Hegazy AN, Schrick C, Fallon PG, Klemenz R, Nakae S, Adler H, Merkler D, Löhning M, and Pinschewer DD. The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses. Science 2012; 335(6071): 984-989.
  • Jackson DJ, Makrinioti H, Rana BMJ, Shamji BWH, Trujillo-Torralbo M-B, Footitt J, Jerico d-R, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, and Johnston SL. IL- 33–Dependent Type 2 Inflammation during Rhinovirus- induced Asthma Exacerbations In Vivo. Am. J. Respir. Crit. Care Med. 2014; 190(12): 1373-1382.
  • Oh JE, Kim B-C, Chang D-H, Kwon M, Lee SY, Kang D, Kim JY, Hwang I, Yu J-W, Nakae S, and Lee HK. Dysbiosis- induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proceedings of the National Academy of Sciences 2016; 113(6): E762-E771.
  • Sattler S, Ling G-S, Xu D, Hussaarts L, Romaine A, Zhao H, Fossati-Jimack L, Malik T, Cook HT, Botto M, Lau Y-L, Smits HH, Liew FY, and Huang F-P. IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut. Journal of Autoimmunity 2014; 50: 107-122.
  • Mizutani N, Nabe T, and Yoshino S. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology 2013; 139(2): 205-18.
Toplam 60 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Research Article
Yazarlar

Özgür Mehmet Yiş Bu kişi benim

Güler Buğdaycı Bu kişi benim

Yayımlanma Tarihi 1 Ocak 2019
Yayımlandığı Sayı Yıl 2019 Cilt: 8 Sayı: 1

Kaynak Göster

APA Yiş, Ö. M., & Buğdaycı, G. (2019). Il-1 ailesi ve ilişkili hastalıklar. Abant Medical Journal, 8(1), 37-45. https://doi.org/10.5505/abantmedj.2019.68094
AMA Yiş ÖM, Buğdaycı G. Il-1 ailesi ve ilişkili hastalıklar. Abant Med J. Ocak 2019;8(1):37-45. doi:10.5505/abantmedj.2019.68094
Chicago Yiş, Özgür Mehmet, ve Güler Buğdaycı. “Il-1 Ailesi Ve ilişkili hastalıklar”. Abant Medical Journal 8, sy. 1 (Ocak 2019): 37-45. https://doi.org/10.5505/abantmedj.2019.68094.
EndNote Yiş ÖM, Buğdaycı G (01 Ocak 2019) Il-1 ailesi ve ilişkili hastalıklar. Abant Medical Journal 8 1 37–45.
IEEE Ö. M. Yiş ve G. Buğdaycı, “Il-1 ailesi ve ilişkili hastalıklar”, Abant Med J, c. 8, sy. 1, ss. 37–45, 2019, doi: 10.5505/abantmedj.2019.68094.
ISNAD Yiş, Özgür Mehmet - Buğdaycı, Güler. “Il-1 Ailesi Ve ilişkili hastalıklar”. Abant Medical Journal 8/1 (Ocak 2019), 37-45. https://doi.org/10.5505/abantmedj.2019.68094.
JAMA Yiş ÖM, Buğdaycı G. Il-1 ailesi ve ilişkili hastalıklar. Abant Med J. 2019;8:37–45.
MLA Yiş, Özgür Mehmet ve Güler Buğdaycı. “Il-1 Ailesi Ve ilişkili hastalıklar”. Abant Medical Journal, c. 8, sy. 1, 2019, ss. 37-45, doi:10.5505/abantmedj.2019.68094.
Vancouver Yiş ÖM, Buğdaycı G. Il-1 ailesi ve ilişkili hastalıklar. Abant Med J. 2019;8(1):37-45.